| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departments of Biochemistry and Molecular Biology [E. L., H. D., L. C. M.] and Pathology [P. H. W.], University of Manitoba, Faculty of Medicine, Winnipeg, Manitoba, R3E OW3, Canada
The expression of the recently described steroid receptor RNA activator (SRA) was measured by semiquantitative reverse transcription-PCR within 27 independent breast tumors, spanning a wide spectrum of grade and estrogen receptor (ER) and progesterone receptor (PR) levels. Subgroup analysis showed that SRA expression was similar in ER+ /PR+ (median = 65.5, n = 8) and in ER-/PR- (median = 94.6, n = 5) tumors. Interestingly, SRA expression in these two subgroups was significantly (Mann-Whitney rank-sum test, P < 0.05) lower than that observed in ER+/PR- (median = 156.4, n = 6) and ER-/PR+ (median = 144.8, n = 8) tumors. A variant form of SRA, presenting a deletion of 203 bp within the SRA core sequence, was also observed in breast tumor tissues. The relative expression of this new SRA isoform correlated with tumor grade (Spearman coefficient r = 0.53, n = 27, P = 0.004). These data suggest that changes in the expression of SRA-related molecules occur during breast tumor progression.
This article has been cited by other articles:
|
|
 |
|
  C. Cooper, J. Guo, Y. Yan, S. Chooniedass-Kothari, F. Hube, M. K. Hamedani, L. C. Murphy, Y. Myal, and E. Leygue Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides Nucleic Acids Res., May 29, 2009; (2009) gkp441v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhao, J. R. Patton, S. K. Ghosh, N. Fischel-Ghodsian, L. Shen, and R. A. Spanjaard Pus3p- and Pus1p-Dependent Pseudouridylation of Steroid Receptor RNA Activator Controls a Functional Switch that Regulates Nuclear Receptor Signaling Mol. Endocrinol., March 1, 2007; 21(3): 686 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Gao, S. K. Mohsin, Z. Gatalica, G. Fu, P. Sharma, and Z. Nawaz Decreased Expression of E6-Associated Protein in Breast and Prostate Carcinomas Endocrinology, April 1, 2005; 146(4): 1707 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Smith and B. W. O'Malley Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators Endocr. Rev., February 1, 2004; 25(1): 45 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Lanz, S. S. Chua, N. Barron, B. M. Soder, F. DeMayo, and B. W. O'Malley Steroid Receptor RNA Activator Stimulates Proliferation as Well as Apoptosis In Vivo Mol. Cell. Biol., October 15, 2003; 23(20): 7163 - 7176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Li, X. Yu, K. Ge, J. Melamed, R. G. Roeder, and Z. Wang Heterogeneous Expression and Functions of Androgen Receptor Co-Factors in Primary Prostate Cancer Am. J. Pathol., October 1, 2002; 161(4): 1467 - 1474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-Q. Ma, Z. Liu, E. S. W. Ngan, and S. Y. Tsai Cdc25B Functions as a Novel Coactivator for the Steroid Receptors Mol. Cell. Biol., December 1, 2001; 21(23): 8056 - 8067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Stomper, C. C. Stewart, and D. L. Stoler Stereotactic Core Biopsy Breast and Blood Cell By-products: A Source of Material for Molecular Genetics Research-Initial Experience Radiology, March 1, 2001; 218(3): 881 - 885. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. C. Murphy, S. L. R. Simon, A. Parkes, E. Leygue, H. Dotzlaw, L. Snell, S. Troup, A. Adeyinka, and P. H. Watson Altered Expression of Estrogen Receptor Coregulators during Human Breast Tumorigenesis Cancer Res., November 1, 2000; 60(22): 6266 - 6271. [Abstract] [Full Text]
|
|
|
|
|
|
S. L. R. Simon, A. Parkes, E. Leygue, H. Dotzlaw, L. Snell, S. Troup, A. Adeyinka, P. H. Watson, and L. C. Murphy Expression of a Repressor of Estrogen Receptor Activity in Human Breast Tumors: Relationship to Some Known Prognostic Markers Cancer Res., June 1, 2000; 60(11): 2796 - 2799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. List, K. J. Lauritsen, R. Reiter, C. Powers, A. Wellstein, and A. T. Riegel Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells J. Biol. Chem., June 22, 2001; 276(26): 23763 - 23768. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
